U.S. stock markets suffered a bloody blow in the first week of August after 19 months of an impressive bull run. Wall Street’s turmoil was triggered by weak labor market data, which heightened concerns of a near-term recession. The massive unwinding of Yen-carry trade due to an unexpected rate hike by the Bank of Japan aggravated the situation. However, U.S. stock markets recovered their lost ground to a great extent within the next 3-4 trading sessions as more released data showed the fundamentals of the U ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Allstate (ALL) .Allstate currently has an average brokerage recom ...

The Allstate Corporation (ALL) reported strong second-quarter results, which benefited on the back of prudent rate increases, rise in Market-based investment income and insurance premiums. Also, improved Property-Liability underwriting results, thanks to its profit improvement plan, lower catastrophe losses and total expenses, aided the bottom line.The second-quarter 2024 adjusted net income of $1.61 per share surpassed the Zacks Consensus Estimate of 33 cents. The company reported a loss of $4.42 per share ...

Allstate (ALL) reported $15.82 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 11.9%. EPS of $1.61 for the same period compares to -$4.42 a year ago.The reported revenue represents a surprise of +1.69% over the Zacks Consensus Estimate of $15.55 billion. With the consensus EPS estimate being $0.33, the EPS surprise was +387.88%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______ to ______ Commission file number 1-11840 THE ALLSTATE CORPORATION (Exact name of registrant as specified in its charter) Delaware 36-3871531 (State or other jurisd ...

Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: | --- | --- | |-----------------|--------------------| | Nick Nottoli | Allister Gobin | | Media Relations | Investor Relations | | (847) 402-5600 | (847) 402-2800 | Allstate Reports Second Quarter 2024 Results Operational execution delivers strong underlying results NORTHBROOK, Ill., July 31, 2024 – The Allstate Corporation (NYSE: ALL) today reported financial results for the second quarter of 2024. The Allstate Corporation Consolidated Highlights | --- | --- | ...

The Allstate Corporation (ALL) is set to report its second-quarter 2024 results on Jul 31, after the closing bell.The Zacks Consensus Estimate for second-quarter earnings is currently pegged at 33 cents per share, implying an improvement of 107.5% from the year-ago reported number. The estimate remained stable over the past week. The Zacks Consensus Estimate for second-quarter revenues is currently pegged at $15.6 billion, suggesting a 10.1% rise from the year-ago actuals. Image Source: Zacks Investment Res ...

Analysts on Wall Street project that Allstate (ALL) will announce quarterly earnings of $0.33 per share in its forthcoming report, representing an increase of 107.5% year over year. Revenues are projected to reach $15.55 billion, increasing 10.1% from the same quarter last year.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this perio ...

ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated1There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transplantation (HSCT) or relapse afterFDA ODD and RPDD designations for UCART22 marks an important step towards developing allogeneic CAR T products that would be readily available for all patients NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) -- C ...

In the latest trading session, Allstate (ALL) closed at $174.83, marking a +0.26% move from the previous day. This move lagged the S&P 500's daily gain of 1.08%. At the same time, the Dow added 0.32%, and the tech-heavy Nasdaq gained 1.58%.Prior to today's trading, shares of the insurer had gained 8.64% over the past month. This has outpaced the Finance sector's loss of 2.72% and the S&P 500's gain of 0.43% in that time.Market participants will be closely following the financial results of Allstate in its u ...